ALTME vs FYB: Side-by-Side Comparison
Compare TME Pharma N.V. (ALTME) and Formycon AG (FYB) side by side: market cap EUR 6.93M vs EUR 337.91M. Financials, growth and model signals on Bullrun.
| Metric | ALTME | FYB |
|---|---|---|
| Company | TME Pharma N.V. | Formycon AG |
| Country / Exchange | Germany · PA | Germany · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 6.93M | EUR 337.91M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 0 | EUR 44.48M |
| Revenue growth YoY | — | -36.2% |
| Net income | EUR -5.72M | EUR -64.70M |
| Gross margin | — | 8.0% |
| Diluted EPS | -0.12 | — |